Filing Details
- Accession Number:
- 0001179110-18-002253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-16 16:04:46
- Reporting Period:
- 2018-02-14
- Accepted Time:
- 2018-02-16 16:04:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1650664 | Editas Medicine Inc. | EDIT | Biological Products, (No Disgnostic Substances) (2836) | 464097528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657434 | F. A. Andrew Hack | C/O Editas Medicine, Inc. 11 Hurley St. Cambridge MA 02141 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-14 | 6,000 | $6.48 | 6,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-14 | 6,000 | $32.71 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-02-15 | 6,000 | $6.48 | 6,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-15 | 6,000 | $34.61 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-02-16 | 6,000 | $6.48 | 6,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-16 | 6,000 | $35.32 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-02-14 | 6,000 | $0.00 | 6,000 | $6.48 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-02-15 | 6,000 | $0.00 | 6,000 | $6.48 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-02-16 | 6,000 | $0.00 | 6,000 | $6.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 75,662 | 2025-09-13 | No | 4 | M | Direct | |
| 69,662 | 2025-09-13 | No | 4 | M | Direct | |
| 63,662 | 2025-09-13 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2017.
- This transaction was executed in multiple trades at prices ranging from $32.27 to $33.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $34.50 to $34.79. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $34.82 to $35.79. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on September 14, 2015 and is scheduled to vest over four years with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019.
Billionaire Hedge Funds
